Drug Shortage Report for SANDOZ REPAGLINIDE
| Report ID | 63497 |
| Drug Identification Number | 02357461 |
| Brand name | SANDOZ REPAGLINIDE |
| Common or Proper name | REPAGLINIDE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | REPAGLINIDE |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 tab |
| ATC code | A10BX |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2018-08-30 |
| Estimated end date | 2019-02-04 |
| Actual end date | 2019-01-31 |
| Shortage status | Resolved |
| Updated date | 2019-02-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2019-02-04 | French | Compare |
| v9 | 2019-02-04 | English | Compare |
| v8 | 2019-01-16 | French | Compare |
| v7 | 2019-01-16 | English | Compare |
| v6 | 2018-12-13 | French | Compare |
| v5 | 2018-12-13 | English | Compare |
| v4 | 2018-11-06 | French | Compare |
| v3 | 2018-11-06 | English | Compare |
| v2 | 2018-10-09 | French | Compare |
| v1 | 2018-10-09 | English | Compare |
Showing 1 to 10 of 10